TGFB1 and melanoma: found that TGFβ pathway inhibition promoted the proliferation expansion of stromal fibroblasts, thereby facilitating MMP9-dependent cleavage of PD-L1 surface expression, leading to PD-1 blockade resistance in melanoma models (51).